Search results for: 'ipsc'

Advancing Neurological and Retinal Research with Genetically Diverse Human iPSC-Derived Models

In this Innovation Showcase webinar, Dr. Andrew Gaffney highlights characterization data for genetically diverse human iPSC lines for the advancement of neurological and retinal disease modeling and drug discovery.

Catalog # WE00290

Show Less

TECH TIP

Frequently Asked Questions on hPSC Characterization Services

Find answers to frequently asked questions (FAQs) about ��ƽ��’s human pluripotent stem cell (hPSC) characterization services.

Catalog # TT00114

Show Less

WEBINAR

ISSCR Standards in Action: Advancements in Cell Line Generation and Organoid Innovation

In this Innovation Showcase, Dr. Gaffney shares the latest advancements in cell line generation, featuring the SCTi003-A and SCTi004-A healthy control iPSC lines. He reviews how these cell lines are shaping the future of stem cell research by setting new

Catalog # WE00261

Show Less

PROTOCOL

How to Differentiate hiPSCs into Colonic Organoids Using STEMdiff™

Step-by-step protocol for differentiating human induced pluripotent stem cell (hiPSC) into colon organoids using STEMdiff™ to model the hindgut.

Catalog # PR00087

Show Less

PROTOCOL

Initiating Intestinal Organoid Differentiation from Single-Cell hPSCs Using STEMdiff™

Step-by-step protocol for initiating intestinal organoid differentiation from single-cell hPSCs using STEMdiff™.

Catalog # PR00084

Show Less

TECH TIP

Frequently Asked Questions on STEMdiff™ Intestinal Organoid Kit

Frequently Asked Questions on STEMdiff™ Intestinal Organoid Kit #html-body [data-pb-style=L1DNMC4]{justify-content:flex-start;display:block;flex-direction:column;background-position:left top;background-size:cover;background-repeat:no-repeat;background-att

Catalog # TT00108

Show Less

VIDEO

Development and QC of SCTi003-A, A Highly Characterized Human iPSC Line for Stem Cell Research

Learn how ��ƽ�� Technologies manufactures and tests iPSCs to IRB-approved and hPSCreg®-certified standards.

Catalog # VD00191

Show Less

WEBINAR

From Academia to Industry: Taking iPSC-Derived Muscle Cells to the Clinic

In this webinar Dr. Peter Andersen, co-founder of Vita Therapeutics, discusses the challenges of moving his research toward the clinic and the key regulatory considerations when building a biotech start-up to launch therapeutics.

Catalog # WE00216

Show Less

BROCHURE

Start with High-Quality Human iPSC Solutions

iPSC Control Line SCTi003-A Data Flyer

Catalog # BR27222

Show Less

PODCAST

“Laser-Based Cell Manipulation” Featuring Dr. Marinna Madrid

Dr. Marinna Madrid from Cellino discusses how lasers and image-guided machine learning can make iPSC-derived cell therapies viable at a large scale.

Catalog # PD00031

Show Less

PODCAST

"Cerebral Organoids" Featuring Dr. Jürgen Knoblich

Dr. Jürgen Knoblich is from the Institute of Molecular Biotechnology at the Austrian Academy of Sciences joins the Stem Cell Podcast to discuss his work using iPSCs and cerebral organoids to investigate inter-brain region interactions, neurodevelopmental

Catalog # PD00011

Show Less

WEBINAR

Modeling Alzheimer's risk using human TREM2-knockout microglia

Catalog # WE00177

Show Less

�����ƽ��

��ƽ��